Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0092
+0.0008 (9.52%)
At close: Dec 5, 2025
-96.83%
Market Cap 575.90K
Revenue (ttm) 2.00K
Net Income (ttm) 1.96M
Shares Out 62.60M
EPS (ttm) 0.40
PE Ratio 0.02
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 716,457
Average Volume 654,418
Open 0.0090
Previous Close 0.0084
Day's Range 0.0084 - 0.0094
52-Week Range 0.0084 - 0.3030
Beta 0.16
RSI 34.38
Earnings Date Apr 3, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.